Monthly Archives: January 2012

Managing in a Cost-Constrained Environment

medicine-thumb

By Jill E. Sackman, D.V.M., Ph.D., Senior Consultant, and Matt Levy, J.D., Business Analyst, at Numerof & Associates, Inc. (NAI) The pharmaceutical industry has entered a critical period of transition. Business models that have proven remarkably successful over the past 20 years are now encountering major challenges. As biotech companies grapple with the leading symptoms of these challenges – pricing pressures, pipeline productivity concerns, a growing public distrust, and greater political and regulatory scrutiny – Read More >

Business of Biotech  |  1 Comment  |  Email This Post
Tags: , , , , ,

Bill Gates: Embrace Genetic Modification or Starve

Bill Gates

Bill Gates has a terse response to criticism that the high-tech solutions he advocates for world hunger are too expensive or bad for the environment:  Countries can embrace modern seed technology and genetic modification or their citizens will starve. When he was in high school in the 1960s, people worried there wouldn’t be enough food to feed the world, Gates recalled in his fourth annual letter, which was published online on January 24 and reported Read More >

Farmer Gene  |  1 Comment  |  Email This Post
Tags: , , , , , ,

The Real Reason Why Salk Refused to Patent the Polio Vaccine

Vaccine

A guest writer in a recent article in the Wall Street Journal repeated the oft quoted Jonas Salk statement about his Polio vaccine: “There is no patent.  Could you patent the sun?”  Many use this statement as the moral impetus for refusing patents on medically important innovations (see Michael Moore’s Capitalism: A Love Story).  Unfortunately, Jonas Salk created a myth that day by leaving out several crucial details. As pointed out by Robert Cook-Deegan at Read More >

Patently BIOtech  |  16 Comments  |  Email This Post
Tags: , , , , , , ,

2011 BIO International Convention Governors Highlight Reel

Deval Patrick

The 2011 BIO International Convention brought together over 15,000 leaders from industry, government and academia who are working to solve some of the sector’s biggest challenges. Last year’s event was a highly successful meeting with representation from all fifty states and 65 nations involved in innovation and manufacturing of life science technologies for the marketplace. We were honored to host governors from 11 U.S. states as they promote their bioscience economic development endeavors. Here’s a Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

Job Skills Training Paves Way for ‘Economy that’s Built to Last’

President Obama

‎Not surprisingly, President Obama’s vision for “an economy built to last,” as outlined in this week’s State of the Union address, makes job creation a cornerstone: “I also hear from many business leaders who want to hire in the United States but can’t find workers with the right skills. Growing industries in science and technology have twice as many openings as we have workers who can do the job. Think about that – openings at Read More >

Public Policy  |  1 Comment  |  Email This Post
Tags: , ,